Effect of Efpeglenatide on Cardiovascular Outcomes

Clinical trial NCT03496298 · TERMINATED

Trial details

NCT number: NCT03496298
Sponsor: Sanofi
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus

Start date: 2018-04-27
Primary completion: 2020-12-10
Enrollment: 4076

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.